Quanwei Zhou

611 total citations
29 papers, 372 citations indexed

About

Quanwei Zhou is a scholar working on Cancer Research, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Quanwei Zhou has authored 29 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Genetics and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Quanwei Zhou's work include Glioma Diagnosis and Treatment (10 papers), Ferroptosis and cancer prognosis (10 papers) and MicroRNA in disease regulation (6 papers). Quanwei Zhou is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Ferroptosis and cancer prognosis (10 papers) and MicroRNA in disease regulation (6 papers). Quanwei Zhou collaborates with scholars based in China, Saudi Arabia and Uganda. Quanwei Zhou's co-authors include Xingjun Jiang, Wen Yin, Caiping Ren, Zhaoping Wu, Guihua Tang, Hecheng Zhu, Zhaoqi Xin, Yudong Cao, Jun Tan and Weidong Liu and has published in prestigious journals such as ACS Nano, Frontiers in Immunology and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Quanwei Zhou

26 papers receiving 371 citations

Peers

Quanwei Zhou
Cunyi Zou China
Stephen Y. Chih United States
Luyan Mu China
Haitao Ge China
Alison Roos United States
Cunyi Zou China
Quanwei Zhou
Citations per year, relative to Quanwei Zhou Quanwei Zhou (= 1×) peers Cunyi Zou

Countries citing papers authored by Quanwei Zhou

Since Specialization
Citations

This map shows the geographic impact of Quanwei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quanwei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quanwei Zhou more than expected).

Fields of papers citing papers by Quanwei Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quanwei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quanwei Zhou. The network helps show where Quanwei Zhou may publish in the future.

Co-authorship network of co-authors of Quanwei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Quanwei Zhou. A scholar is included among the top collaborators of Quanwei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quanwei Zhou. Quanwei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ma, Chengcheng, Jiawen Chen, Yang Liu, et al.. (2024). Therapeutic modulation of APP-CD74 axis can activate phagocytosis of TAMs in GBM. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167449–167449. 12 indexed citations
3.
Tang, Yifan, Changjiang Gu, Junkai Zeng, et al.. (2024). Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis. Molecular Medicine. 30(1). 57–57. 5 indexed citations
4.
Zhou, Quanwei, et al.. (2024). Machine learning algorithms for predicting glioma patient prognosis based on CD163+FPR3+ macrophage signature. npj Precision Oncology. 8(1). 201–201. 8 indexed citations
6.
Zhou, Quanwei, et al.. (2023). Spinal extradural arachnoid cysts: A novel formation mechanism and dural defect location technology. Heliyon. 9(1). e12969–e12969. 1 indexed citations
7.
Li, Shasha, et al.. (2023). TANK shapes an immunosuppressive microenvironment and predicts prognosis and therapeutic response in glioma. Frontiers in Immunology. 14. 1138203–1138203. 2 indexed citations
8.
Zhu, Hecheng, Ming Zhao, Quanwei Zhou, et al.. (2022). Potential mechanisms underlying the promoting effects of 3D collagen scaffold culture on stemness and drug resistance of glioma cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(11). 166522–166522. 7 indexed citations
9.
Zhou, Quanwei, Chenxi Peng, Jiaheng Li, et al.. (2022). FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies. Frontiers in Oncology. 12. 880077–880077. 19 indexed citations
10.
Xu, Hongjuan, Hecheng Zhu, Weiren Luo, et al.. (2022). TBL1X and Flot2 form a positive feedback loop to promote metastasis in nasopharyngeal carcinoma. International Journal of Biological Sciences. 18(3). 1134–1149. 17 indexed citations
11.
12.
Zhu, Hecheng, Quanwei Zhou, Wen Yin, et al.. (2022). The role of lncRNA just proximal to XIST (JPX) in human disease phenotypes and RNA methylation: The novel biomarker and therapeutic target potential. Biomedicine & Pharmacotherapy. 155. 113753–113753. 6 indexed citations
13.
Cao, Yudong, Ya Shi, Zhifeng Xiao, et al.. (2021). Contralateral Axon Sprouting but Not Ipsilateral Regeneration Is Responsible for Spontaneous Locomotor Recovery Post Spinal Cord Hemisection. Frontiers in Cellular Neuroscience. 15. 730348–730348. 6 indexed citations
14.
Cao, Yudong, Hecheng Zhu, Jun Tan, et al.. (2021). Development of an Immune-Related LncRNA Prognostic Signature for Glioma. Frontiers in Genetics. 12. 678436–678436. 12 indexed citations
15.
Zhou, Quanwei, Hecheng Zhu, Zhaoqi Xin, et al.. (2021). Identification of three tumor antigens and immune subtypes for mRNA vaccine development in diffuse glioma. Theranostics. 11(20). 9775–9790. 34 indexed citations
16.
Yin, Wen, Hecheng Zhu, Jun Tan, et al.. (2021). Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma. Cancer Cell International. 21(1). 276–276. 44 indexed citations
17.
Zhou, Quanwei, Hecheng Zhu, Weidong Liu, et al.. (2021). The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas. iScience. 24(11). 103249–103249. 9 indexed citations
18.
Jiang, Zhipeng, Wen Yin, Hecheng Zhu, et al.. (2021). METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis. Cancer Cell International. 21(1). 383–383. 16 indexed citations
19.
Yin, Wen, Xingjun Jiang, Jun Tan, et al.. (2020). Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma. Frontiers in Oncology. 10. 1409–1409. 53 indexed citations
20.
Yin, Wen, Guihua Tang, Quanwei Zhou, et al.. (2019). Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma. Frontiers in Genetics. 10. 419–419. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026